GlassScriptPhysician profile
Vivek Menon
NPI 1073889622
$68,233.22
in general payments reported to CMS, 2019-2025
30 companies · $8,852 in 2025
The $8,852 reported for 2025 was more than what 78% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $211 · 2020: $703 · 2021: $3,380 · 2022: $6,398 · 2023: $38K · 2024: $11K · 2025: $8,852.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $29K · Food and Beverage: $16K · Travel and Lodging: $11K · Education: $1,086 · Consulting Fee: $344.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $29,488.00 |
| Food and Beverage | $15,641.46 |
| Travel and Lodging | $10,982.03 |
| Education | $1,085.90 |
| Consulting Fee | $343.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $25,673.12 | 2022-2025 | Ensite Precision, Ensite, Advisor |
| Medtronic, INC. | $20,946.92 | 2022-2025 | Evera Mri Xt Dr Surescan, Micra, Cobalt Dr Mri Surescan |
| Biotronik INC. | $7,231.75 | 2021-2023 | Acticor 7 Vr-T Dx, Renamic Neo, Biomonitor |
| Boston Scientific Corporation | $6,409.22 | 2020-2025 | General - Therapies, Farapulse, Essentio Sr |
| Biosense Webster, INC. | $3,288.52 | 2023-2025 | Carto 3, Octaray Mapping Catheter |
| Astrazeneca Pharmaceuticals LP | $920.50 | 2020-2022 | |
| Roche Molecular Systems, INC. | $687.50 | 2022-2023 | |
| Pfizer INC. | $418.53 | 2019-2022 | |
| Cardiva Medical, INC. | $330.92 | 2024-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Janssen Pharmaceuticals, INC | $287.51 | 2020-2023 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $277.33 | 2019-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $216.31 | 2021-2022 | |
| Abiomed | $177.02 | 2022 | |
| Kestra Medical Technology Services, INC. | $164.86 | 2024 | Assure Wcd |
| Cook Medical LLC | $161.90 | 2023-2024 | Evolution |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $145.34 | 2023 | Optimizer |
| Baxter Healthcare | $143.10 | 2024 | Perclot |
| Chiesi USA, INC. | $141.88 | 2020-2021 | |
| Grifols USA, LLC | $118.43 | 2022-2023 | Prolastin-C Liquid |
| Novo Nordisk INC | $113.47 | 2022 | |
| Novartis Pharmaceuticals Corporation | $71.35 | 2021-2025 | |
| Elutia, INC. | $68.08 | 2024 | Ecm Patch,Pouch |
| Ethicon US, LLC | $59.06 | 2023-2024 | Ethicon, Stratafix, Dermabond Prineo |
| Philips North America LLC | $49.99 | 2025 | Igt Devices Undivided |
| Cordis US Corp. | $34.31 | 2024 | Mynx Control |
| Merck Sharp & Dohme LLC | $33.29 | 2021-2023 | Verquvo, Belsomra |
| Mylan Specialty L.P. | $18.81 | 2023 | Yupelri |
| Akcea Therapeutics, INC. | $17.62 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.00 | 2022 | |
| Amgen INC. | $11.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vivek Menon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.